A murine model of myocardial microvascular thrombosis

Journal of Clinical Investigation

Volumn 104, Issue 5, 1999, Pages 533-539

  Christie, Patricia D ^a   Edelberg, Jay M ^a,b   Picard, Michael H ^c   Foulkes, Andrea S ^d   Mamuya, Wilfred ^a,e   Weiler Guettler, Hartmut ^f   Rubin, Robert H ^a   Gilbert, Peter ^d   Rosenberg, Robert D ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FIBRINOLYSIS; GENOTYPE; HEART MUSCLE NECROSIS; HEMOSTASIS; HISTOLOGY; INTRACARDIAC THROMBOSIS; MICROVASCULARIZATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL MODEL;

EID: 0032702982     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7141     Document Type: Article

References (41)

1. Aird, W.C., et al. 1997. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol. 138:1117-1124.
2. Edelberg, J.M., et al. 1998. PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102:837-843.
3. Sawdey, M.S., and Loskutoff, D.J. 1991. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J. Clin. Invest. 88:1346-1353.
4. Weiler-Guettler, H., Aird, W.C., Husain, M., Rayburn, H., and Rosenberg, R.D. 1996. Targeting of transgene expression to the vascular endothelium of mice by homologous recombination at the thrombomodulin locus. Circ. Res. 78:180-187.
5. Speiser, W., Anders, E., Preissner, K.T., Wagner, O., and Müller-Berghaus, G. 1987. Differences in coagulant and fibrinolytic activities of cultured human endothelial cells derived from omental tissue microvessels and umbilical veins. Blood. 69:964-967.
6. Dalager-Pedersen, S., Ravn, H.B., and Falk, E. 1998. Atherosclerosis and acute coronary events. Am. J. Cardiol. 82:37T-40T.
7. Fuster, V. 1994. Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology [erratum 1995, 91:256]. Circulation. 90:2126-2146.
8. Epstein, F. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115-135.
9. Verdouw, P.D., van den Doel, M.A., de Zeeuw, S., and Duncker, D.J. 1998. Animal models in the study of myocardial ischaemia and ischaemic syndromes. Cardiovasc. Res. 39:121-135.
10. Jonker, J.J.C., and Chesebro, J.H. 1992. Chronic coronary disease. In Thrombosis in cardiovascular disorders. V. Fuster and M. Verstraete, editors. W.B. Saunders Co. Philadelphia, PA. 363-373.
11. Selwyn, A.P., Kinlay, S., Craeger, M., Libby, P., and Ganz, P. 1997. Cell dysfunction in atherosclerosis and ischemic manifestations of coronary artery disease. Am. J. Cardiol. 97:17-23.
12. Esmon, C.T. 1993. Cell mediated events that control blood coagulation and vascular injury. Annu. Rev. Cell Biol. 9:1-26.
13. Rock, G., and Wells, P. 1997. New concepts in coagulation. Crit. Rev. Clin. Lab. Sci. 34:475-501.
14. Cines, D.B., et al. 1998. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:3527-3561.
15. Esmon, C.T., and Owen, W.G. 1981. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc. Natl. Acad. Sci. USA. 78:2249-2252.
16. Collen, D., and Lijnen, H.R. 1991. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 78:3114-3124.
17. Weiler-Guettler, H., et al. 1998. A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J. Clin. Invest. 101:1983-1991.
18. Carmeliet, P., et al. 1994. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 368:419-424.
19. Hui, K.Y., Haber, E., and Matsueda, G.R. 1983. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science. 222:1129-1132.
20. Kudryk, B., Rohoza, A., Ahadi, M., Chin, J., and Wiebe, M.E. 1984. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol. Immunol. 21:89-94.
21. Seber, G.A.F. 1977. Linear regression analysis. John Wiley & Sons. New York, NY. 125-139.
22. Christensen, R. 1987. Plain answers to complex questions: the theory of linear models. Springer-Verlag. New York, NY. 45-78.
23. Dvorak, H.F., Form, D.M., Manseau, E.J., and Smith, B.D. 1984. Pathogenesis of desmoplasia. I. Immunofluorescence identification and localization of some structural proteins of line 1 and line 10 guinea pig tumors and of healing wounds. J. Natl. Cancer Inst. 73:1195-1205.
24. Prophet, E.B., Mills, B., Arlington, J.B., and Sobrin, L.E. 1994. Laboratory methods in histotechnology. American Registry of Pathology. Washington, DC. 132-133.
25. Lodge, P.A., Haisch, C.E., and Thomas, F.T. 1992. A simple method of vascular endothelial cell isolation. Transplant. Proc. 24:2816-2817.
26. Nishida, M., Springhorn, J.P., Kelly, R.A., and Smith, T.W. 1993. Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture. J. Clin. Invest. 91:1934-1941.
27. Scherrer-Crosbie, M., et al. 1999. Three-dimensional echo assessment of left ventricular wall motion abnormalities in mouse myocardial infarction. J. Am. Soc. Echocardiogr. In press.
28. Levin, E.G., Santell, L., and Osborn, K.G. 1997. The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic location. J. Cell Sci. 110:139-148.
29. Levin, E.G., Osborn, K.G., and Schleuning, W.D. 1998. Vessel-specific gene expression in the lung: tissue plasminogen activator expression is limited to bronchial arteries and pulmonary vessels of discrete size. Chest. 114(Suppl. 1):68S.
30. Wagner, S.N., et al. 1996. Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem. Cell Biol. 105:53-60.
31. Ford, V.A., Stringer, C., and Kennel, S.J. 1992. Thrombomodulin is preferentially expressed in Balb/c lung microvessels. J. Biol. Chem. 267:5446-5450.
32. Bugge, T.H., et al. 1996. Urokinase-rype plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc. Natl. Acad. Sci. USA. 93:5899-5904.
33. George, E.L., Baldwin, H.S., and Hynes, R.O. 1997. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood. 90:3073-3081.
34. Suh, T.T., et al. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9:2020-2033.
35. Erickson, R.P. 1996. Mouse models of human genetic disease: which mouse is more like a man? Bioessays. 18:993-998.
36. Bajzar, L., Nesheim, M., Morser, J., and Tracy, P.B. 1998. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor. J. Biol. Chem. 273:2792-2798.
37. Bajzar, L., Nesheim, M.E., and Tracy, P.B. 1996. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood. 88:2093-2100.
38. Hosaka, Y., Takahashi, Y., and Ishii, H. 1998. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombm-dependent activation of plasma procarboxypeptidase B. Thromb. Haemost. 79:371-377.
39. Nesheim, M. 1998. Fibrinolysis and the plasma carboxypeptidase. Curr. Opin. Hematol. 5:309-313.
40. Wilhelm, S., Wilhelm, O., Schmitt, M., and Graeff, H. 1994. Inactivation of receptor-bound pro-urokinase-type plasminogen activator(pro-uPA) by thrombin and thrombin/thrombomodulin complex. Biol. Chem. Hoppe Seyler. 375:603-608.
41. Healy, A.M., Hancock, W.W., Christie, P.D., Rayburn, H.B., and Rosenberg, R.D. 1998. Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin deposition. Blood. 92:4188-4197.